A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression. - Related Studies

A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression.

This study is ongoing, but not recruiting participants.

Study NCT00566202. Last updated on November 20, 2008. Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Major Depressive Disorder

2	Additional conditions recognized in this trial
		Depression
		Depressive Disorder
		Depressive Disorder, Major
		Disease

3	More general conditions related to this trial
		Behavioral Symptoms
		Mental Disorders
		Mood Disorders
		Pathologic Processes

4	Interventions listed in this trial
		placebo
		JNJ-18038683
		escitalopram

5	Additional drug interventions recognized in this trial
		Citalopram
		Dexetimide

6	More general drug interventions related to this trial
		Anti-Dyskinesia Agents
		Antidepressive Agents
		Antidepressive Agents, Second-Generation
		Antiparkinson Agents
		Autonomic Agents
		Central Nervous System Agents
		Cholinergic Agents
		Cholinergic Antagonists
		Molecular Mechanisms of Pharmacological Action
		Muscarinic Antagonists
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Parasympatholytics
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Serotonin Agents
		Serotonin Uptake Inhibitors
		Therapeutic Uses

7	Sponsors listed in this trial
		Johnson &Johnson Pharmaceutical Research &Development, L.L.C.